All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors.

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Abstract Text:

Harold L Lazar,Harold L Lazar,Harold L Lazar,

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Publishing Authors By Initials

HL Lazar,HL Lazar,HL Lazar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Journal Published:

PUBLICATION TYPE: Editorial

Journal: Circulation

VOLUME: 117

Page Numbers: 6-8

Journal Abbreviation: Circulation

ISSN: 1524-4539

DAY: 1

MONTH: Jan

YEAR: 2008

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 147763

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Circulation

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors Related Publications

• A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
• Activating physicians within a hospital emergency plan: a concept whose time has come?
• Age, response complexity, and target consistency in visual search.
• All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors.
• Altering the direction of optokinetic head nystagmus: a lesion study and a hypothetical model.
• Analysis of Metallothionein, RCAS1 Immunoreactivity Regarding Immune Cell Concentration in the Endometrium and Tubal Mucosa in Ectopic Pregnancy during the Course of Tubal Rupture.
• Bifunctional role of Rev-erbalpha in adipocyte differentiation.
• Brain activity associated with stimulation therapy of the visual borderzone in hemianopic stroke patients.
• CSF fistula in a patient with Mondini deformity: demonstration by CT cisternography.
• Evidence for intermediate S-states as initial phase in the process of oxygen-evolving complex oxidation.
• How insurers, purchasers, and employers view their need for guidelines: report of Washington Business Group on Health--AHCPR focus groups.
• Insurance status and untreated dental caries in Virginia schoolchildren.
• Lung cancer as a second primary malignant tumor: prognostic values after surgical resection.
• Microfluidic platform with mass spectrometry detection for the analysis of phosphoproteins.
• Migration of an endovascular stent from superior vena cava to the right ventricular outflow tract in a patient with superior vena cava syndrome.
• Neurobehavioral differences in superselective Wada testing with amobarbital versus lidocaine.
• Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue.
• Pemphigus acutus treated with antibiotics.
• Peripheral arterial disease in HIV-infected and uninfected women.
• Relationship between aortic atherosclerosis and non-invasive measures of arterial stiffness.
• Resistin- and Obesity-associated metabolic diseases.
• Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways.
• Rheumatoid factor and malignant disease.
• The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks.
• The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1.
• The thermodynamic driving force for bone growth and remodelling: a hypothesis.
• [Cancer mortality in smaller regions with different structures and conditions of air quality]
• [Lobectomy performed through a video-assisted mini thoracotomy, as a new technique in our clinical practice.]
• [Prediction of preeclampsia using the integrated test markers]
• [Pregnancy and environment. Influence of the socioeconomic level on prematurity]